Virocomb N 150 mg/300 mg/200 mg Tablet
By Virocomb N
Rx
60 Tablet in a Bottle

Composition
Lamivudine(150mg) + Zidovudine(300mg) + Nevirapine(200mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
July, 2026

liver
When using Virocomb N 150 mg/300 mg/200 mg Tablet, it is important to be cautious if you have liver disease. Adjustments to the dosage of Virocomb N 150 mg/300 mg/200 mg Tablet may be necessary in such cases, and it is essential to consult your doctor before taking this medication. It is advised not to use Virocomb N 150 mg/300 mg/200 mg Tablet if you have moderate to severe liver disease. Regular monitoring of liver function tests is recommended while using this medicine to ensure your safety and well-being.

kidney
Virocomb N 150 mg/300 mg/200 mg Tablet needs caution in patients with kidney disease. Adjusting the dose may be necessary. Consult your doctor for guidance.

alcohol
When taking Virocomb N 150 mg/300 mg/200 mg Tablet, caution is advised when consuming alcohol. It is recommended to consult your doctor.

driving
When using Virocomb N 150 mg/300 mg/200 mg Tablet, be cautious while driving as it may cause fatigue, impacting your ability to drive safely due to possible side effects.

pregnancy
Virocomb N 150 mg/300 mg/200 mg Tablet may be unsafe during pregnancy. Limited human studies and animal research suggest potential harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Virocomb N 150 mg/300 mg/200 mg Tablet is likely safe during breastfeeding. It poses minimal risk to your baby based on limited data available.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹1177
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024